Tuesday , June 25 2019

New 63 billion mega buy in biofarm

The American group AbbVie announces the acquisition of its compatriot Allergen, a Botox maker, for about 63 billion dollars (55.3 billion euros). A new big acquisition in the biotechnology sector. AbbVie , …

Read More »